drugset / Trial / NCT06583863

Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission

NCT06583863

Completed 120 enrolled Benha University
RandomizedParallel-groupSingle-blindTreatment

Summary

The study aimed to explore the link between parasitic infections and the severity of ulcerative colitis (UC). 120 UC patients were divided into three groups: those without infection, those with Giardia lamblia infection treated with metronidazole, and those with Giardia infection treated with a combination of metronidazole and E. purpurea. The results revealed that patients with Giardia infections exhibited more severe UC symptoms. All groups experienced improved symptoms following treatment, but the combination therapy group demonstrated the most significant improvement. Remission rates were highest in the group without infection and the group receiving combination therapy. Additionally, the study identified E. purpurea therapy and a substantial reduction in SCCAI score as significant predictors of higher remission rates.

Timeline

Start
2023-09-12
Primary completion
2024-04-01
Completion
2024-06-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator ECHINACEA, UNSPECIFIED Traditional medicine (herbal / TCM) 175 mg
Comparator Metronidazole Small molecule 500 mg Oral

Indications